News About: Pharm. Industry
Wholesalers to opt for either Zuellig or direct trade.
The drug wholesalers who were associating with Zuellig while directly dealing with drug makers who relied their business wholly on drug wholesalers (hereinafter called an outsourcing drug company) now have to make a c...
Jeil Science Award to Prof. Sohn and Oh.
Korea Continence Society and Jeil Pharm. Co. jointly established an award called "Jeil Science Award" and celebrated the award event on Oct. 22 during the 10th annual conference of the Korea Continence Society at Seou...
Seminar for patent disputes implicated with generic drugs.
Korea Drug Research Association (KDRA) planned a seminar titled "A successful patent strategy for the marketing of generic drugs in Korea and overseas markets" at the hall of Korea Invention Promotion Association from...
GSK campaign for prevention of hepatitis.GSK sponsored a violin concert titled "Kang Dong-suk hope concert for the world without worries of hepatitis"at Seoul Art Center on Oct. 26, where demonstrated an imprompt event...
|
CJ to invest 50 billion won for 10 years on cell therapy.
As a mid and long term strategy CJ Pharmaceutical Division planned to put the total 50 billion won of investment for 10 years on cell therapy using the stem cells.
CJ will establish "CJ venture No.8 bio investment ...
Hanseo to invest 1 billion won for bio R&D infra.
Hanseo announced on Oct. 27 that the total one billion won of investment would be made to Bio Infra and Nuvex, where Prof. Kim Cheol-woo of SNU hospital is the CEO and a majority shareholder, and these two companies a...
Il Yang trying to transform into an ethical drug company.
Il Yang took a company business report meeting at Yeoido on Oct. 27 including the business performance during the first half of this year and the current R&D of new drugs.
President Yoo Tae-wook said in the meeting...
Il Yang to obtain KFDA approval on anti-cancer bulk drug.Il Yang has obtained the KFDA approval for the manufacturing licence of an anti-cancer bulk drug, which was developed from an organism of mushroom called Phellinus linteus for t...
|
Kwangdong to expand Vita500 sales to Taiwan.
Kwangdong Pharm. Co. signed an agreement with Manpoong business group of Taiwan on Oct. 19 for Vita500 sales in Taiwan.
Taiwan has only a tablet form of vitamin C market at about 62 billion won of value in 2004,...
LG on strategic alliance with Kyorin for urine incontinence drug.LG Life Science signed an agreement of strategic allicance for the market and development of Uritos (imidafenacin), a new therapeutic drug for the incontinence of urine, with Ky...
|
